1. Home
  2. ELOG vs LSTA Comparison

ELOG vs LSTA Comparison

Compare ELOG & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ELOG

Eastern International Ltd. Ordinary Shares

N/A

Current Price

$1.15

Market Cap

23.3M

Sector

Industrials

ML Signal

N/A

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$1.94

Market Cap

20.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELOG
LSTA
Founded
2006
1980
Country
China
United States
Employees
N/A
N/A
Industry
Integrated Freight & Logistics
Misc Health and Biotechnology Services
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.3M
20.9M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
ELOG
LSTA
Price
$1.15
$1.94
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$23.50
AVG Volume (30 Days)
1.9M
28.0K
Earning Date
02-10-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
59.27
N/A
EPS
0.16
N/A
Revenue
$45,962,309.00
$1,070,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.22
N/A
Revenue Growth
10.64
N/A
52 Week Low
$0.88
$1.81
52 Week High
$3.60
$4.20

Technical Indicators

Market Signals
Indicator
ELOG
LSTA
Relative Strength Index (RSI) N/A 35.16
Support Level N/A $1.81
Resistance Level N/A $2.17
Average True Range (ATR) 0.00 0.11
MACD 0.00 -0.00
Stochastic Oscillator 0.00 19.44

Price Performance

Historical Comparison
ELOG
LSTA

About ELOG Eastern International Ltd. Ordinary Shares

Eastern International Ltd is a holding company. The company operates through its subsidiary engaged in domestic and cross-border professional logistic services including project logistics and general logistics for company clients. Its project logistic services include Construction project logistics and special cargo logistics for large or precision equipment and General logistic services refer to the transportation, warehousing, loading and unloading, and distribution of ordinary products. Its segments are Transportation services and Warehouse subleasing services. The group generates the majority of its revenue from Transportation services.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: